Publications by authors named "R M Chaoui"
Firsttrimester Diagnosis and Therapy @ 11 - 13 Weeks of Gestation - Part 1 : Guideline of the DEGUM, ÖGUM, SGUMGG, DGGG, ÖGG, Gynecologie Suisse, DGPM, DGPGM, BVF, ACHSE (AWMF S2e LL 085-002 1.1.2024) (https://register.awmf.org/de/leitlinien/detail/085-002).
Geburtshilfe Frauenheilkd
October 2024
This extensive AWMF 085-002 S2e-guideline "First Trimester Diagnosis and Therapy @ 11 - 13 of Gestation" has systematically analyzed high-quality studies and publications and the existing evidence (evidence tables) and produced recommendations (level of recommendation, level of evidence, strength of consensus). This guideline deals with the following topics in the context of the 11 - 13 weeks scan: the legal basis, screening for anatomical malformations, screening for chromosomal defects, quality assessment and audit, screening for preeclampsia and FGR, screening for preterm birth, screening for abnormally invasive placenta (AIP) and placenta accreta spectrum (PAS), screening for velamentous cord insertion and vasa praevia, screening for diabetes mellitus and LGA. Screening for complications of pregnancy can best be carried out @ 11 - 13 weeks of gestation.
View Article and Find Full Text PDFFirsttrimester Diagnosis and Therapy @ 11 - 13 Weeks of Gestation - Part 2 : Guideline of the DEGUM, ÖGUM, SGUMGG, DGGG, ÖGG, Gynecologie Suisse, DGPM, DGPGM, BVF, ACHSE (AWMF S2e LL 085-002 1.1.2024) (https://register.awmf.org/de/leitlinien/detail/085-002).
Geburtshilfe Frauenheilkd
October 2024
Article Synopsis
- The AWMF 085-002 S2e-guideline provides detailed recommendations based on high-quality studies for screening and managing pregnancy complications during the 11-13 weeks of gestation scan.
- Key topics include screening for anatomical malformations, chromosomal defects, preeclampsia, and other conditions, with solutions for identifying many issues already in place.
- While some complications can be effectively screened and managed in early pregnancy, challenges remain in identifying disorders related to glucose metabolism and preterm birth, making early detection crucial for better outcomes in pregnancy management.
Article Synopsis
- - The AWMF 085-002 S2e-guideline provides detailed recommendations based on high-quality studies for screening and diagnosing various pregnancy-related issues between 11-13 weeks of gestation, including anatomical malformations and chromosomal defects.
- - It emphasizes the importance of first-trimester screening for complications such as preeclampsia, abnormal placentation, and growth retardation, noting that some identification methods are effective while others, like glucose metabolism disorders, remain insufficient.
- - The guideline also highlights that early diagnosis allows for better management of pregnancy complications, including the option for lower-risk terminations if needed, and reassures parents through appropriate follow-ups, reducing unnecessary examinations.
Article Synopsis
- The AWMF 085-002 S2e-guideline provides evidence-based recommendations for diagnosing and managing various pregnancy complications during the critical 11-13 week scan.
- It covers topics such as screening for anatomical malformations, chromosomal defects, preeclampsia, and other significant conditions, providing clarity on how to identify these issues.
- While many screening challenges have been addressed, some like glucose metabolism disorders and preterm birth remain unresolved, emphasizing the importance of early screening for better pregnancy management.
Article Synopsis
- Anomalous origin of the left pulmonary artery (AOLPA) is a rare congenital heart defect that requires careful detection during fetal echocardiography.
- A 30-year-old pregnant woman had a fetal scan that identified AOLPA and a right-sided aortic arch, allowing for better planning of her delivery.
- Early detection of AOLPA through prenatal diagnosis is essential for improving outcomes, highlighting the need for thorough examination during fetal echocardiography.